{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:58:47Z","timestamp":1778860727346,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Medical Research Council Norway","award":["234424\/H10"],"award-info":[{"award-number":["234424\/H10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2344-2","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T01:23:16Z","timestamp":1514424196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"18","author":[{"name":"the BREATHE study team","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gonzalez-Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kranzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilda","family":"Mujuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rowland-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tore J.","family":"Gutteberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond","family":"Flaegstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon O.","family":"Odland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashida A.","family":"Ferrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"2344_CR1","doi-asserted-by":"publisher","unstructured":"Weber HC, Gie RP, Cotton MF. The challenge of chronic lung disease in HIV-infected children and adolescents. J Int AIDS Soc. 2013;16:18633. doi\n10.7448\/IAS.16.1.18633\n\n.","DOI":"10.7448\/IAS.16.1.18633"},{"key":"2344_CR2","doi-asserted-by":"publisher","unstructured":"Rylance J, Meghji J, Miller RF, Ferrand RA. Global considerations in human immunodeficiency virus-associated respiratory disease. Semin Respir Crit Care Med. 2016;37(2):166\u201380. doi:\n10.1055\/s-0036-1572555\n\n.","DOI":"10.1055\/s-0036-1572555"},{"key":"2344_CR3","doi-asserted-by":"publisher","unstructured":"Desai SR, Copley SJ, Barker RD, et al. Chest radiography patterns in 75 adolescents with vertically-acquired human immunodeficiency virus (HIV) infection. Clin Radiol. 2011;66(3):257\u201363. doi:\n10.1016\/j.crad.2010.10.009\n\n.","DOI":"10.1016\/j.crad.2010.10.009"},{"key":"2344_CR4","doi-asserted-by":"publisher","unstructured":"Ferrand RA, Desai SR, Hopkins C, et al. Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis. 2012;55(1):145\u201352. doi:\n10.1093\/cid\/cis271\n\n.","DOI":"10.1093\/cid\/cis271"},{"key":"2344_CR5","doi-asserted-by":"publisher","unstructured":"Mwalukomo T, Rylance SJ, Webb EL, et al. Clinical characteristics and lung function in older children vertically infected with human immunodeficiency virus in Malawi. J Pediatric Infect Dis Soc. 2016;5(2):161\u20139. doi:\n10.1093\/jpids\/piv045\n\n.","DOI":"10.1093\/jpids\/piv045"},{"issue":"18","key":"2344_CR6","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1097\/QAD.0000000000001249","volume":"30","author":"J Rylance","year":"2016","unstructured":"Rylance J, McHugh G, Metcalfe J, et al. Chronic lung disease in HIV-infected children established on antiretroviral therapy. AIDS. 2016;30(18):2795\u2013803.","journal-title":"AIDS"},{"key":"2344_CR7","doi-asserted-by":"publisher","unstructured":"Githinji LN, Gray DM, Hlengwa S, Myer L, Zar HJ. Lung function in South African adolescents infected perinatally with HIV and treated long-term with antiretroviral therapy. Ann Am Thorac Soc. 2017;14(5):722\u20139. doi:\n10.1513\/AnnalsATS.201612-1018OC\n\n.","DOI":"10.1513\/AnnalsATS.201612-1018OC"},{"key":"2344_CR8","doi-asserted-by":"publisher","unstructured":"Attia EF, Weiss NS, Maleche Obimbo E, McGrath CJ, Cagle A, West TE, El Antouny NG, Attwa M, Crothers K, Chung MH. Risk factors for hypoxia and tachypnea among adolescents with vertically-acquired HIV in Nairobi. Pediatr Infect Dis J. 2017;36(4):e93\u20137. doi:\n10.1097\/INF.0000000000001453\n\n.","DOI":"10.1097\/INF.0000000000001453"},{"key":"2344_CR9","doi-asserted-by":"publisher","unstructured":"Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics. 2011;127(2):e423\u201341. doi:\n10.1542\/peds.2009-701\n\n.","DOI":"10.1542\/peds.2009-701"},{"key":"2344_CR10","unstructured":"Du Plessis AM, Andronikou S, Zar H. High resolution computed tomography for chronic small airway disease in HIV infected adolescents. Presented at the 53rd annual Pediatric Radiology Conference, Davos; 2017. \nhttp:\/\/espr2017.org\/mwg-internal\/de5fs23hu73ds\/progress?id=-XIs7GAX9PH5860DTYU4X9joMtIwTaXbvr07B0633oM"},{"key":"2344_CR11","doi-asserted-by":"publisher","unstructured":"Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr Opin Pediatr. 2008;20(3):272\u20138. doi:\n10.1097\/MOP.0b013e3282ff62e9\n\n.","DOI":"10.1097\/MOP.0b013e3282ff62e9"},{"key":"2344_CR12","doi-asserted-by":"publisher","unstructured":"Fischer GB, Sarria EE, Mattiello R, Mocelin HT, Castro-Rodriguez JA. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev. 2010;11(4):233\u20139. doi:\n10.1016\/j.prrv.2010.07.005\n\n.","DOI":"10.1016\/j.prrv.2010.07.005"},{"key":"2344_CR13","doi-asserted-by":"publisher","unstructured":"Haddad IY. Stem cell transplantation and lung dysfunction. Curr Opin Pediatr. 2013;25(3):350\u20136. doi:\n10.1097\/MOP.0b013e328360c317\n\n.","DOI":"10.1097\/MOP.0b013e328360c317"},{"key":"2344_CR14","doi-asserted-by":"publisher","unstructured":"Uhlving HH, Buchvald F, Heilmann CJ, Nielsen KG, Gormsen M, Muller KG. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transplant. 2012;47(8):1020\u20139. doi:\n10.1038\/bmt.2011.161\n\n.","DOI":"10.1038\/bmt.2011.161"},{"key":"2344_CR15","doi-asserted-by":"publisher","unstructured":"Tenorio AR, Zheng Y, Bosch RJ, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014;210(8):1248\u201359. doi:\n10.1093\/infdis\/jiu254\n\n.","DOI":"10.1093\/infdis\/jiu254"},{"key":"2344_CR16","doi-asserted-by":"publisher","unstructured":"Macatangay BJ, Yang M, Sun X, et al. Brief report: changes in levels of inflammation after antiretroviral treatment during early HIV infection in AIDS Clinical Trials Group Study A5217. J Acquir Immune Defic Syndr. 2017;75(1):137\u201341. doi:\n10.1097\/QAI.0000000000001320\n\n.","DOI":"10.1097\/QAI.0000000000001320"},{"key":"2344_CR17","doi-asserted-by":"publisher","unstructured":"Sereti I, Krebs SJ, Phanuphak N, et al. Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection. Clin Infect Dis. 2017;64(2):124\u201331. doi:\n10.1093\/cid\/ciw683\n\n.","DOI":"10.1093\/cid\/ciw683"},{"issue":"2","key":"2344_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.bmt.1705026","volume":"36","author":"F Ratjen","year":"2005","unstructured":"Ratjen F, Rjabko O, Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant. 2005;36(2):135\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2344_CR19","doi-asserted-by":"publisher","unstructured":"Kingah PL, Muma G, Soubani A. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis. Clin Transplant. 2014;28(8):906\u201310. doi:\n10.1111\/ctr.12401\n\n.","DOI":"10.1111\/ctr.12401"},{"key":"2344_CR20","doi-asserted-by":"publisher","unstructured":"Lam DC, Lam B, Wong MK, et al. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT\u2014a randomized double-blinded placebo-controlled study. Bone Marrow Transplant. 2011;46(12):1551\u20136. doi:\n10.1038\/bmt.2011.1\n\n.","DOI":"10.1038\/bmt.2011.1"},{"key":"2344_CR21","doi-asserted-by":"publisher","unstructured":"Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):660\u20137. doi:\n10.1016\/S0140-6736(12)60953-2\n\n.","DOI":"10.1016\/S0140-6736(12)60953-2"},{"key":"2344_CR22","doi-asserted-by":"publisher","unstructured":"Cramer CL, Patterson A, Alchakaki A, Soubani AO. Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. Postgrad Med. 2017;129(5):493\u20139. doi:\n10.1080\/00325481.2017.1285677\n\n.","DOI":"10.1080\/00325481.2017.1285677"},{"issue":"5","key":"2344_CR23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200601-071OC","volume":"174","author":"GM Verleden","year":"2006","unstructured":"Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2006;174(5):566\u201370.","journal-title":"Am J Respir Crit Care Med"},{"key":"2344_CR24","doi-asserted-by":"publisher","unstructured":"Liu Y, Pu Y, Li D, Zhou L, Wan L. Azithromycin ameliorates airway remodeling via inhibiting airway epithelium apoptosis. Life Sci. 2017;170:1\u20138. \n10.1016\/j.lfs.2016.11.024\n\n.","DOI":"10.1016\/j.lfs.2016.11.024"},{"key":"2344_CR25","doi-asserted-by":"publisher","unstructured":"Southern KW, Barker PM, Solis-Moya A, Patel L. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2012;11:CD002203. doi:\n10.1002\/14651858.CD002203.pub4\n\n.","DOI":"10.1002\/14651858.CD002203.pub4"},{"key":"2344_CR26","doi-asserted-by":"publisher","unstructured":"Valery PC, Morris PS, Byrnes CA, et al. Long-term azithromycin for indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2013;1(8):610\u201320. doi:\n10.1016\/S2213-600(13)70185-1\n\n.","DOI":"10.1016\/S2213-600(13)70185-1"},{"key":"2344_CR27","doi-asserted-by":"publisher","unstructured":"Li YN, Liu L, Qiao HM, Cheng H, Cheng HJ. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr. 2014;14:238. doi:\n10.1186\/471-2431-14-238\n\n.","DOI":"10.1186\/471-2431-14-238"},{"key":"2344_CR28","doi-asserted-by":"publisher","unstructured":"Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2014;2(5):361\u20138. doi:\n10.1016\/S2213-600(14)70019-0\n\n.","DOI":"10.1016\/S2213-600(14)70019-0"},{"issue":"7","key":"2344_CR29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/sim.5667","volume":"32","author":"BC Kahan","year":"2013","unstructured":"Kahan BC, Morris TP. Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects? Stat Med. 2013;32(7):1136\u201349.","journal-title":"Stat Med"},{"key":"2344_CR30","unstructured":"International Conference on Harmonisation Guideline for International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Guideline for Good Clinical Practice E6 (R1). ICH Harmonised Tripartite Guideline. 1996. \nhttps:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf\n\n. Accessed 27 Mar 2017."},{"key":"2344_CR31","doi-asserted-by":"publisher","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, Hr\u00f3bjartsson A, Mann H, Dickersin K, Berlin J, Dor\u00e9 C, Parulekar W, Summerskill W, Groves T, Schulz K, Sox H, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137. doi:\n10.7326\/0003-4819-158-3-201302050-00583\n\n.","DOI":"10.7326\/0003-4819-158-3-201302050-00583"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T01:23:40Z","timestamp":1514424220000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2344-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2344-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"622"}}